BNP Paribas Financial Markets Has $15.85 Million Stake in Chemed Co. (NYSE:CHE)

BNP Paribas Financial Markets raised its stake in Chemed Co. (NYSE:CHE - Free Report) by 36.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 26,381 shares of the company's stock after purchasing an additional 7,007 shares during the quarter. BNP Paribas Financial Markets owned 0.18% of Chemed worth $15,854,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Chemed by 2.6% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company's stock worth $314,868,000 after purchasing an additional 14,651 shares in the last quarter. William Blair Investment Management LLC increased its holdings in shares of Chemed by 2.7% in the second quarter. William Blair Investment Management LLC now owns 475,372 shares of the company's stock valued at $257,927,000 after purchasing an additional 12,705 shares during the last quarter. Impax Asset Management Group plc boosted its position in shares of Chemed by 4.7% during the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company's stock worth $199,977,000 after buying an additional 14,814 shares during the period. TD Asset Management Inc raised its stake in Chemed by 10.9% in the second quarter. TD Asset Management Inc now owns 282,753 shares of the company's stock valued at $153,416,000 after buying an additional 27,800 shares in the last quarter. Finally, FMR LLC grew its holdings in shares of Chemed by 23.8% during the third quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after buying an additional 45,917 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Analyst Upgrades and Downgrades

CHE has been the subject of several research reports. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Saturday. Royal Bank of Canada cut their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th.

Insider Transactions at Chemed

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the company's stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the transaction, the executive vice president now directly owns 6,109 shares in the company, valued at approximately $3,478,159.15. This represents a 21.90 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the transaction, the director now owns 3,046 shares in the company, valued at $1,819,893.62. This represents a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,845 shares of company stock worth $3,978,798. 3.32% of the stock is currently owned by company insiders.

Chemed Price Performance

Shares of Chemed stock traded up $1.08 on Friday, hitting $572.39. The company had a trading volume of 45,670 shares, compared to its average volume of 97,532. The company has a market cap of $8.61 billion, a PE ratio of 28.92, a PEG ratio of 2.43 and a beta of 0.46. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62. The business has a 50-day simple moving average of $578.27 and a 200-day simple moving average of $565.07.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same period last year, the business earned $5.32 EPS. The company's quarterly revenue was up 7.4% on a year-over-year basis. On average, equities research analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed's dividend payout ratio is 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.